Form 4: Cargo Therapeutics Director, John A. Orwin, Acquires Stock Options
SEC Form 4 Filing
Director John A. Orwin acquired stock options for 23,742 shares of Cargo Therapeutics, Inc. on June 4, 2024.
Summary
- On June 4, 2024, John A. Orwin, a director of Cargo Therapeutics, Inc., acquired stock options for 23,742 shares.
- The exercise price of these options is $19.17 per share.
- The options vest on the earlier of June 4, 2025, or the next Annual Meeting following June 4, 2024, contingent upon continued service to the Issuer.
- The options expire on June 3, 2034.
Sentiment
Score: 5
Explanation: This is a routine filing related to stock option grants, indicating standard compensation practices. It doesn't inherently suggest positive or negative sentiment, but rather reflects ongoing management incentives.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, such as directors, offering insights into their confidence in the company's future performance.
Stakeholder Impact
- The granting of stock options aligns the director's interests with those of the shareholders, incentivizing them to work towards increasing the company's value.
Key Dates
| Date | Description |
|---|---|
| 06/04/2024 | Date of the stock option transaction. |
| 06/04/2024 | Vesting Commencement Date. |
| 06/03/2034 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.